KB407A Study Assessing KB407 for the Treatment of Cystic Fibrosis

Sponsor:

Krystal Biotech, Inc.

Code:

NCT05504837

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KB407 (Nebulization)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Krystal Biotech, Inc. on 2026-05-07.